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1. Abstract 
 
The cardiovascular benefits of regular exercise are well established. High-intensity 
endurance exercise induces electrical, structural, and functional adaptations in the 
heart in order to sustain the increased cardiac output and metabolic needs. These 
cardiac changes are called ‘athletes heart’ and include typical morphological changes 
(eccentric hypertrophy) and a slowing of the heart rate with significant brady- and 
tachy-arrythmias. The heart rhythm depends on the intrinsic heart rate, generated by 
the pacemaker cells in the sinus node, and on the autonomic (parasympathetic and 
sympathetic) tone. Bradycardia in endurance athletes is commonly attributed to an 
increased vagal tone. Recently, D’Souza and colleagues have instead demonstrated 
that, in rodent, training-induced bradycardia is due to an intrinsic modification of the 
heart. In particular, they showed that bradycardia persists (in vivo) after blockade of 
the autonomous nervous system in mice and (in vitro) in the isolated heart. 
Furthermore, they demonstrated a reduction of the If pacemaker current in sinoatrial 
node (SAN) cells of trained mice. The molecular mechanism at the basis of this 
process is not completely understood but our collaborators in Manchester showed 
also a training-dependent  up-regulation of miR-1, one of the main myomiR, and of 
miR-423. 
The aim of this work is to understand the role of miR-1 and miR-423 in sinoatrial 
cells. Given the difficulty to keep SAN cells in culture, we decided to study the role of 
these microRNAs in sinoatrial-like cells differentiated from mESC overexpressing 
them. To do this, we generated three different clones of mouse embryonic stem cells 
overexpressing miR-1, miR-423 and a control line. The overexpression of these 
miRNAs affected neither the pluripotency nor the capacity of mESC to differentiate 
into cardiomyocytes. We selected CD166+ sinoatrial-like cells from differentiating 
mESC by flow cytometry and found that the proportion of CD166+ SAN-like cells is 
higher in mESC-miR1 (25.20±2.32% n=26) and in mESC-miR423 (18.56±1.36% n=9) 
than in control lines (11.09±1.09% n=30).  
Electrophysiological analysis showed a lower firing rate in miR-1-CD166+ cells than 
in cells from the control line, while no differences are present between miR-423-
CD166+ and empty-CD166+ (miR-1-CD166+ 1.37±0.08Hz n=10; miR-423-CD166+ 
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2.36±0.30Hz n=7; empty-CD166+ 2.22±0.22Hz n=7). We further demonstrated that 
the miR-1 overexpression leads to around a 50% reduction of the funny current.  
We found no differences in the expression level of miR-423 in miR-423-CD166+ and 
empty-CD166+, despite it resulted overexpressed in mESC-miR-423 respect to 
mESC-empty. We then studied the effect of miR-423 by transiently overexpressing it 
in neonatal rat ventricular cardiomyocytes, finding again no differences. 
These data demonstrated that miR-1 modulates the beating frequency of sinoatrial-
like cells, reducing the If current, and thus demonstrating that miR-1 contribute to the 
establishment of the endurance athletes’ bradycardia. For what concern  miR-423, 
from our data it seems to have no effect in the control of cardiac rate, however, since 
the overexpression of miR-423 was modest in mESC and we could not control the 
expression level in transfected neonatal rat ventricular cardiomyocytes further 
experiments are needed to definitely rule out its contribution to exercise-induced 
bradycardia.  
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2. Introduction 
 
2.1 The Heart  
 
Fig. 1:  anatomy of the heart, frontal section.   
 
The heart is a hollow and muscular organ, it acts as a mechanical pump allowing 
blood circulation into the body. It is composed by four cavities, divided by a septum 
into two non-communicating sectors, the right and left heart. Each sector is 
composed of an atrium (upper chamber) and a ventricle (lower chamber). Atria and 
ventricles are connected by the atrioventricular (AV) valves that allows the blood to 
flow only from the atria to the ventricles. The AV valve on the right side of the heart is 
called tricuspid, while the valve on the left side is termed mitral or bicuspid. Atria are 
smaller and have thinner muscular walls than ventricles. Ventricles, on the other 
hand, have thicker myocardial walls, with the left much thicker than the right, 
because it has to pump blood throughout the high resistance systemic circulation. 
The right atrium receives the blood low in oxygen from the superior and inferior vena 
cava and sends it to the right ventricle, which sends out the blood through the 
pulmonary valves to the pulmonary artery and to the lungs; here the blood is 
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oxygenated and comes back to the heart from the pulmonary veins to the left atrium, 
after that it goes into the left ventricle and to all body through the aortic valves and 
the aorta. The pulmonary and the aortic valves are the semilunar valves and they 
prevent the return of blood from arteries to ventricles. 
The heart is located into the chest, in the lower anterior mediastinum and leans on 
the diaphragm. It is located into the pericardium, that is a serous membrane that 
produces a serous fluid that reduces friction and allows the movements of the heart. 
The pericardium has one parietal and one visceral layer; the second one is intimately 
connected to the heart forming the epicardium, the outer of the three layers of the 
heart wall. The other two are the endocardium, a squamous endothelium that covers 
the interior surface of the heart, and the myocardium, the muscular middle layer that 
makes up the majority of the thickness and mass of the heart.  
 
 
Fig. 2:  layers of the heart. 
 
The heart is composed of different types of muscle cells, which are commonly 
classified into contractile myocardium and conduction system. The contractile cells 
are the cells of the working myocardium connected through low-resistant gap 
junctions; in this way every cell of the heart is electrically coupled to the next one and 
the heart can be considered a functional syncytium. The working myocardium 
represents the major portion of atria and ventricles. Instead, cells of the conduction 
system are specialized cells  involved in the generation and propagation of the action 
7 
 
potentials to allow the spontaneous contraction of the heart. The conduction system 
is composed of the sinoatrial node (SAN), the atrioventricular node (AVN), the bundle 
of His, and the Purkinje fibers. The SAN is located into the right atrium near the 
entrance of the superior vena cava and generates spontaneous action potentials. 
This action potentials propagate to the rest of the heart and thus the SAN is the 
pacemaker region. The action potentials will first be propagated to the atria that are 
the first structures to contract and from there, the signal reaches the AVN, located in 
the right posterior portion of the interatrial septum. The AVN has two main functions: 
conducting the depolarization from atria to ventricles, indeed AVN is normally the 
only conductive link between the two chambers, and delaying the spread of 
excitation, allowing the consecutive contraction of atria and ventricles. The AVN is in 
connection with the bundle of His that divides first into two branches and then into the 
Purkinje fibers, an extensive network of fibers that conducts action potential very 
rapidly throughout the ventricles.   
 
 
Fig. 3: conducting system of the heart. 
 
All the components of the conduction system are able to spontaneously generate 
action potentials, but the SAN does it at a higher rate, concealing the activity of the 
other portions through a mechanism known as “overdrive suppression”.  
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The heart is innervated by the autonomic nervous system, which is divided into the 
sympathetic and parasympathetic branches. Sympathetic stimulation of the heart 
induces an increment of heart rate, force of muscular contraction, and of conduction 
velocity and it acts releasing norepinephrine that binds to  β-receptors. 
Parasympathetic stimulation has the opposite effects, which are mediated by 
acetylcholine that binds to muscarinic receptors. Under resting condition, both 
autonomic divisions send stimuli to the heart, and especially to the SAN, but normally 
in humans the dominant influence is parasympathetic. Thus, although the heart beats 
spontaneously, it exhibits a vagal tone and the heart rate is usually lower than the 
intrinsic rate.  
 
 
2.2 The action potential 
The action potential represents the changes in voltage of a single cardiac cell. 
Different action potentials could be recorded in different regions of the heart. There 
are two primary types of action potentials: atria and ventricles have fast-response 
action potentials, while SAN and AVN cells display a slow-response action potentials.  
Fast-response action potentials could be subdivided into five phases (Fig. 4): 
 Phase 0 (fast depolarization): this phase is characterized by a rapid upstroke 
due to a fast Na+ current (INa). The sodium channels have an opening 
threshold around -70mV, while the cells have a resting potential of -90mV, so 
it is necessary a depolarizing stimulus in order to start the action potential that 
comes from the depolarization of the adjacent cell.  
 Phase 1: it represents a small and transient repolarization caused by the 
opening of a special type of transient outward K+ channel (Ito). 
 Phase 2: it is the plateau phase of the action potential. This plateau phase is 
due to the balance of inward calcium currents generated by calcium channels 
(ICaL and ICaT) and outward potassium currents (IKr, IKs) that maintains  the 
membrane potential near 0mV for about 200ms, prolonging the action 
potential duration and permitting the excitation-contraction coupling.  
 Phase 3: during this phase the membrane potential repolarizes to the resting 
value, thanks to the inactivation of  calcium channels and the active presence 
of potassium channels; the potassium currents responsible for this phase are 
the rapid (IKr) and slow (IKs) component of the delayed outward currents. 
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 Phase 4: the membrane potential is maintained at the resting value of about -
90mV by the inward rectifier current (IK1) until the incoming of a new 
depolarizing stimulus. 
 
 
Fig. 4: schematic representation of fast response action potential. 
 
Slow-response action potential: 
The main characteristic of the SAN cells is the ability to generate regular and 
spontaneous action potentials, known as “slow response” action potential (Fig. 5). 
The main characteristic of the slow response action potential is the absence of both a 
true resting potential and a plateau phase. It is characterized by the following phases: 
 Phase 4: early diastolic depolarization (EDD). In these cells, there is not a 
resting potential, and the most negative potential that the cells reach 
between two APs is called Maximum Diastolic Potential (MDP). This phase is 
characterized by the activation of a slow, inward, depolarizing current, called 
“funny” current (If) (DiFrancesco, 1986 b). This current leads to a 
depolarization of the membrane potential. It is also present a spontaneous 
calcium release from the sarcoplasmic reticulum that contributes to the late 
phase of the diastolic depolarization by activating the Na+/Ca++ exchanger 
(Lakatta & DiFrancesco, 2009). The EDD phase of slow-response action 
potential is also characterized by the absence of Ik1. 
 Phase 0: this phase is characterized by a depolarizing calcium current 
mediated by both Transient (T-type) and Long-lasting (L-type) calcium 
channels. The T-type calcium channels have a threshold of -60mV, while the 
L-type starts to activate at more positive potential (around -40 mV). 
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Therefore in the slow response action potential the up-stroke phase is not 
due to a sodium current, but to a calcium current, so the steepned of this 
phase is lower in SAN than in ventricles.   
 Phase 3: this phase is characterized by the inactivation of calcium channels 
and by the opening of potassium channels (Mangoni and Nargeot 2008). 
 
 
Fig. 5: schematic representation of slow response action potential. 
 
 
2.3 The If current and the HCN channels 
The funny current (If, pacemaker current) was first described in the SAN (Brown et al., 
1979) and was extensively characterized originally in this tissue and in Purkinje fibers 
(DiFrancesco et al., 1986 a; DiFrancesco, 1986 b; Brown et al., 1980; DiFrancesco et 
al., 1980; DiFrancesco, 1981 a; DiFrancesco, 1981 b). This current has peculiar 
characteristics: it is a mixed current of sodium and potassium and it is activated by 
both membrane hyperpolarization, with a threshold of approximately -30/-40mV, and 
cyclic nucleotides.  
The molecular component of the pacemaker current is the Hyperpolarization-
activated Cyclic Nucleotide-gated channel (HCN), that is a family composed of 4 
members (HCN1, HCN2, HCN3, and HCN4), belonging to the superfamily of voltage-
gated K+ (Kv) and CNG channels; they have a tetrameric composition (Ulens & 
Siegelbaum, 2003; Zagotta et al., 2003), and each subunit is composed of 6 
transmembrane domains (S1–6); the segment S4 is the voltage sensor. The pore of 
the HCN channels is composed of the GYG sequence, typical of potassium 
11 
 
channels, and the C-terminus contains the CNBD, the cyclic nucleotide-binding 
domain, that confers sensitivity to cyclic nucleotides (Viscomi et al., 2001). Direct 
binding of cAMP molecules to the C-terminus of pacemaker channels increases the 
opening probability of HCN channels via a positively-directed shift of the voltage 
dependence of the activation curve, whereas a reduced intracellular cAMP 
concentration gives rise to the opposite action (DiFrancesco & Tortora, 1991). The 
intracellular concentration of cAMP is modulated by the binding of sympathetic and 
parasympathetic neurotransmitters to β-adrenergic and muscarinic receptor, 
respectively; consequently, the If current is modulated by the autonomic nervous 
system. As previously described, the If current is involved in the EDD phase of action 
potential, so an increase or a decrease of the net current leads to a change in the 
slope of EDD and therefore to an increase or decrease of the firing rate (DiFrancesco 
e Borer, 2007). Pacemaker channels, and specifically HCN4 isoform, are confined, 
together with the β2-adrenergic receptors (β2-ARs), to membrane caveolae, cellular 
microdomains whose function is to keep in close proximity proteins involved in a 
specific signal transduction pathway (Barbuti et al., 2007).  
 
 
Fig. 6. HCN channels structure. 
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Fig. 7. schematic representation of HCN cannels regulation by autonomic nervous system. ACh = 
acetylcholin, AC = adenylate cyclase, β-AR = β-adrenergic receptor, Gi = inhibitory G protein, Gs = 
stimulatory G protein, M2-R = Muscarinic receptor type-2, NA = noradrenalin (DiFrancesco e Borer, 
2007). 
 
 
The If pacemaker current is predominantly, but not exclusively, expressed in the 
conduction system of the heart, indeed it is present also in the working myocardium 
but at much lower level and its physiological role is not completely clear. However, it 
seems to be involved in pathologic conditions, for example, If is upregulated in 
ventricular myocytes of hypertrophic hearts as a consequence of remodeling, leading 
to the hypothesis that it may contribute to arrhythmias in chronic hypertension and 
cardiac failure, a condition associated with increased risk for sudden cardiac death 
(Cerbai et al., 2006). Moreover, the HCN channels are differently distributed in 
different heart regions, in particular HCN4 is the main isoform of SAN cells despite 
HCN1 and 2 being expressed at lower level. HCN2 is expresses at very low level in 
ventricles and atria (Shi et al., 1999; Brioschi et al., 2009). The different HCN channel 
isoforms have some common characteristics, in particular, the transmembrane 
segments, the core region and the CNBD are extremely conserved but they have 
differences at N- and C- terminus, in the activation and deactivation kinetics and in 
the affinity to cyclic nucleotides (Viscomi et al., 2001; Altomare et al., 2001; Zagotta 
et al., 2003). 
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2.4 SAN development 
The heart derives from the embryonic mesoderm, organized in the “primitive heart 
tube” that after the cardiac looping further develops forming the cardiac chambers 
(Moorman e Christoffels, 2003). The SAN precursors develop from the region of the 
sinus venosus, which separates from the rest of cardiac mesoderm at day 8 (E8) of 
differentiation. At E8.5 these precursors are characterized by the specific expression 
of a series of transcription factors such as Tbx18, Isl-1 while do not express Nkx2.5, 
a transcription factor that, together with Tbx5, is responsible for the specification of 
the working myocardium (Mommersteeg et al., 2010). At E9.5 Tbx3 and Shox2 start 
to be expressed in those precursors that will form the conduction system; Tbx3 is a 
transcription factor that specifically inhibits the expression of Nppa and Cx40, 
characteristic of atrial tissue, Shox2 is instead essential for the inhibition of Nkx2.5 
(Hoogaars et al., 2004; Espinoza-lewis et al., 2009). Another fundamental 
transcription factor for the correct development of the SAN is Pitx2c, indeed, while 
the sinus venosus is a symmetric structure, the SAN originates only in the right 
atrium and Pitx2c specifically suppresses the SAN gene pathway in the left region, 
allowing the correct asymmetric development (Mommersteeg et al., 2007; Barbuti 
and Robinson 2015).  
 
Fig. 8: schematic representation of genes involved in SAN development (from Barbuti and Robinson 
2015). 
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2.5 Embryonic stem cells  
Embryonic stem cells (ESCs) are pluripotent stem cells derived from the inner cell 
mass of the blastocyst. ESCs are able to perpetuate themselves ad infinitum (self-
renewal), and to generate differentiated progeny. ESCs can divide symmetrically and 
asymmetrically, in the first case they generate two daughter cells with the same fate 
expanding the pool of stem cells, while in the second situation they originate two cells 
with different fates: one will maintain the pool of ESC, the other one gives origin to 
the differentiated progeny. The balance between symmetric and asymmetric division 
is controlled by environmental signals to produce the right number of stem cells and 
differentiated daughters (Morrison et al., 2006).  
ESCs are pluripotent and consequently they are able to differentiate in all cells of the 
three germ layers.  
 
 
 Fig. 9: schematic mammalian embryo at the blastocyst stage. ICM: inner cellular mass (De Miguel et 
al., 2010). 
 
The first mouse embryonic stem cells (mESC) were isolated in the 80s. It is possible 
to culture mESC in vitro for a long time, in the presence of LIF (Leukemia Inhibitory 
Factor) (Matsui et al., 1992). mESCs express specific marker of pluripotency, like 
glycolipids stage specific embryonic antigen (SSEA-1) or Oct4, Nanog, and Sox2, 
that are transcription factors that have an essential role in the regulatory circuitry 
needed to maintain an undifferentiated state and self-renewal (De Miguel et al., 
2010). 
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It is possible to induce the differentiation of mESC in all cell types in vitro, through the 
formation of Embryoid Bodies (EBs), macroscopic structures that recapitulate the 
early stage of embryo development and contains cells of all three germ layers.  
 
 
2.6 Isolation of sinoatrial-like cells 
 
 
Fig. 10: example of HD technique to EBs differentiation (Hescheler et al., 1997) 
 
As previously described, EBs are composed of cells of all three germ layers, and one 
of the first lineage that appears is the cardiac type. One of the most common and 
well-defined protocol to obtain beating EBs is based on the hanging drops (HDs) 
technique. This protocol permits the formation of EBs, that in 80-90% of the cases 
displays spontaneous beating activity (Wobus et al., 1991). It is well known that the 
cardiomyocytes population into EBs is heterogeneous; atrial-, ventricular-, and 
sinoatrial-like action potentials could be distinguished (Maltsev et al., 1993).    
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Fig. 11: representative action potentials recorded from cardiomyocytes in EBs (Maltsev et al., 1994). 
 
Since the heterogeneity of cells obtained from differentiating mESCs it is necessary 
to tune a protocol to isolate only cardiac cells, and possibly to discriminate the 
different cardiac phenotype.  
Several approaches were attempted, based on cell-engineering, pharmacology, and 
analysis of expression markers. Many groups tried to isolate cardiomyocytes from 
EBs, using a reporter gene: they generated mESCs line expressing a reporter gene, 
like eGFP, under the control of a promoter of a cardiac gene, like ANP (Atrial 
Natriuretic Peptide), α-MHC (Alpha-myosin heavy chain), mink, and GATA6. In all 
these cases, a mixed population of atrial- and sinoatrial-like cells was obtained 
(Gassanov et al., 2004; Kolossov et al., 2005; White and Claycomb, 2005). Hidaka 
and colleagues isolated a mixed population of ventricular-, atrial-, and sinoatrial-like 
cells using the eGFP under the control of Nkx2.5, a transcription factor involved in 
chamber formation (Hidaka et al., 2003). The selection based on the activity of HCN4 
promoter did not allow to select a pure population of SAN cells, indeed, even though 
the expression of HCN4 and of the funny current is necessary, it is not sufficient to 
identify SAN cells, since HCN4 is also expressed by other cell types during 
embryonic development (Morikawa et al., 2010; Scavone et al., 2013).  
Different approaches based on the use of drugs were also developed in order to 
improve cardiac differentiation, without even manipulating the cell genome: treatment 
with suramin or ET-1 (endothelin-1), for example, increased the percentage of 
sinoatrial-like cells, while treatment with retinoic acid pushed the differentiation 
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toward the atrial lineage. However, these approaches did not allow to obtain a pure 
population (Wiese et al., 2011; Gassanov et al., 2004; Hidaka et al., 2003).   
Recently, our laboratory demonstrated that it is possible to isolate a specific 
population of sinoatrial-like cells on the basis of the expression of CD166 in EBs from 
mouse embryonic stem cells at a specific time point of differentiation (day 8). CD166, 
known also as ALCAM (Activated Leucocytes Cell-Adhesion Molecule) or DM-
GRASP, is a transmembrane protein, and an adhesion molecule of the Ig 
superfamily; it is the natural ligand of the human CD6 receptors (Ibáñez et al., 2006).  
In mice, during heart formation, CD166 is specifically and transiently expressed in the 
sinus venus, the region from which the SAN develops, (Hirata et al., 2006; Murakami 
et al., 2007). We showed that 24 hours after cell sorting, CD166+, but not CD166-, 
starts to beat spontaneously. We demonstrated that CD166+ cells, unlike CD166-, 
express high levels of the specific cardiac markers α-Actinin, cTnI, Mef2c, and 
GATA4. We also showed that CD166+ cells express Tbx18, Tbx3, Isl-1, and Shox2, 
which are important for SAN development, and also proteins important in the adult 
SAN, like ion channels (HCN4, HCN1, CaV1.3, Cav3.2), connexins (Cx30.2), and 
sarcomeric proteins (ssTnI). Furthermore, CD166+ cells express at very low levels 
genes typical of the ventricle (Nkx2.5, Kv4.2, HCN2, and Cx43). It was also 
demonstrated that CD166+ cells express HCN4 at the protein level and they display 
the If current, but also the L- and the T-type calcium currents; CD166+ cells express 
also β-adrenergic and muscarinic receptors, and could be modulated by 
isoproterenol and acetylcholine (sympathetic and parasympathetic agonist, 
respectively). Interestingly, CD166+ cells have a low proliferative potential, don’t 
express markers of pluripotency (Oct4, Nanog, and Rex1), and do not form 
teratomas in vivo (Scavone at al., 2013). Therefore in our laboratory it was 
demonstrated the possibility of isolate a population with the molecular and functional 
properties typical of sinoatrial cells using CD166 as a marker.  
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Fig. 12: (A) quantitative expression analysis of cardiac genes (cTnI, Mef2c, and GATA-4) in embryonic 
stem cells (ES) and in CD166+, and CD166- cells sorted at day 8 of differentiation. (B) confocal 
images of CD166+ cells labelled with caveolin-3 (cav-3, green) and HCN4 (red); nuclei were stained 
with DAPI. (C) representative traces of If current, recorded from single CD166+ cell, and 
representative action potentials recorded from both CD166+ cells and SAN cells, in control and under 
superfusion of 50µmol/L of nickel (Ni
2+
) and 100nmol/L Nifedipine. (D) spontaneous action potentials 
recorded from CD166+ cells in control and under superfusion of 1µmol/L isoproterenol (Iso) and 
0.1µmol/L acetylcholine (ACh); the bar graph shows the mean rate changes caused by the autonomic 
agonists. (E) Quantitative expression analysis of genes of pluripotency (Oct-4, Nanog, and Rex1) in 
embryonic stem cells (ES) and in CD166+ and CD166- cells sorted at day 8 of differentiation. 
(modified from Scavone et al., 2013). 
 
 
 
2.7 Exercise and heart 
The cardiovascular benefits of regular exercise are well established and include a 
better pressure control, improved blood lipid profile, reduced risk of prostate and 
breast cancer, reduced risk of osteoporosis, increased self-confidence, and it’s 
considered anti-depressant; in addition, exercise is associated with a significant 
reduction in cardiac events. It is important to underlie that the amount of exercise 
required to reach these benefits is relatively modest. The current guidelines 
recommend a minimum of 150 minutes of moderate exercise per week, while 
professional athletes perform approximately 20 hours of intense exercise. The effects 
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of chronic endurance exercise may result in a series of cardiac modifications called 
“athletes heart” that ensure the possibility to sustain the increased cardiac output and 
metabolic needs of the organism. These cardiac modifications include typical 
morphological changes (increase in left ventricular wall thickness, increase in both 
left and right ventricular cavity and in aortic diameter), and a slowing down of the 
heart rate with significant brady- and tachy-arrythmias. The changes described above 
are commonly considered benign and generally reversible after detraining, but in the 
last few years, several studies suggested that endurance exercise could be 
associated with myocardial remodeling and fibrosis, but also with an increased risk of 
atrial fibrillation in athletes compared to sedentary people. This idea is supported also 
by animal studies: for example, Benito and collaborators showed that after 10 weeks 
of training, rats display fibrosis in atria and ventricles and diastolic dysfunction 
(Benito et al., 2011). Consequently, extreme high intensity training might not only 
have physiological but also pathologic consequences, like fibrillation, bradycardia, 
and atrioventricular conduction abnormalities (Baldesberger et al., 2008; Sharma et 
al., 2015; Maron and Pelliccia., 2006).  
Endurance trained athletes are well known to show sinus bradycardia with episodes 
of resting heart rate lower than 30 beats per minute. Despite bradycardia being 
considered a physiological condition, it could become pathologic resembling the 
sinus node disease. As previously described, the setting of heart rate essentially 
depends on: the intrinsic heart rate, generated by sinoatrial node cell, and by the 
modulation of the autonomic nervous system. The mechanism at the basis of 
bradycardia in endurance athletes is controversial, but it is commonly attributed to an 
increased vagal tone on the pacemaker cells (Smith et al. 1989; Jensen-Urstad et al. 
1997; Coote & White, 2015). Conversely, using a murine model of endurance, 
D’Souza and colleagues have recently demonstrated that training-induced 
bradycardia is not a consequence of an alteration in the autonomic nervous system, 
but it is due to an intrinsic modification of the heart. In particular, they showed that 
bradycardia persists (in vivo) after blockade of the autonomous nervous system in 
mice and (in vitro) in the isolated heart both in trained mice and rats. They also found 
no differences in vagal tone of sedentary and trained mice. Furthermore, D’Souza 
and colleagues demonstrated a reduction of the If pacemaker current in sinoatrial 
node (SAN) cells of trained mice and a reduction of HCN4 (the molecular component 
of the If current) at mRNA and protein level in trained rats. The molecular mechanism 
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at the basis of this process is not completely understood but they also showed an up-
regulation of miR-1, one of the main myomiR, following chronic exercise (D’Souza et 
al., 2014).  
 
 
Fig. 13: (A) representative ECG traces obtained from sedentary and trained rats and mice; heart rates 
measured in vivo and in vitro in sedentary and trained animals (rats and mice); mean heart rate 
measured in vivo in mice at baseline and after complete autonomic block; mean sympathetic tone and 
vagal tone in conscious sedentary and trained mice. (B) downregulation of HCN4 mRNA and protein 
levels in SAN of trained mice. (C) Representative traces and mean current density of If current 
recorded in SAN cells of sedentary and trained mice. (D) Mean miR-1 levels in sinus node and right 
atrium in sedentary and trained mice: miR-1 results up-regulated in SAN of trained mice (modified 
from D’Souza et al., 2014). 
 
 
2.8 MicroRNA 
MicroRNAs (miRNAs) are small non-coding RNAs of 20-25 nucleotides length. They 
regulate gene expression at post-transcriptional level by annealing to inexactly 
complementary sequences in the 3’-UTR regions of the target messenger RNA 
(mRNA). The crucial region for the target recognition is the “miRNA seed” located at 
the 5’ of miRNA and long from 2 to 7 nucleotides (Lewis et al., 2005; Ha and Kim, 
2014). miRNAs are involved in many physiological and pathological processes, and 
most of the human coding genes are under their control (Freidman et al., 2009). 
Therefore, miRNAs represent a very important class of gene-regulatory molecules 
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and consequently, their level and function are strongly regulated at multiple steps, 
from biogenesis to processing and turnover.  
 
 
Fig. 14: schematic representation of canonical microRNA biogenesis pathway (Kim et al., 2009). 
 
The transcription of the primary transcripts, the pri-miRNAs, is usually mediated by 
RNA polymerase II (Pol II), from independent genes or from introns of protein-coding 
genes; the pri-miRNA contains a stem-loop structure of several kilobases. The first 
step of maturation is mediated by the Microprocessor complex, composed of the 
RNase III-type Drosha and its cofactor DGCR8, and consists in the cleavage of the 
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hairpin structures. As a result, there is the formation of the pre-miRNA, a small 
hairpin. The pre-miRNA is then exported from the nucleus to the cytoplasm, by the 
exportin 5 (EXP5), where is cleaved by Dicer in proximity of the terminal loop, 
obtaining a ~22nt miRNA duplex (miRNA/miRNA*), that is loaded into an Ago protein 
forming, with other cofactors, the RISC effector complex. In this way, Drosha and 
Dicer determine the two end of future mature miRNA. Probably a helicase removes 
the unselected strand of the miRNA duplex; the relative thermodynamic stability of 
the two ends of the duplex has to determine which strand is selected and it is usually 
the filament with relatively unstable base pairs at the 5’ that survives. Generally, most 
miRNA genes produce one dominant miRNA, but the ratio between the miRNA and 
miRNA* can vary in different developmental stages or tissues and, since the 
selection is not a stringent process, miRNAs are sometimes produced from both 
strands at comparable level. As mentioned before, stringent regulation of miRNA 
levels is fundamental in order to maintain the cellular functions. One of the first point 
of regulation is the miRNA transcription, indeed it depends on different transcription 
factors and epigenetic control; the pri-miRNA processing by Drosha is also 
considered a regulatory step and depends on many different co-regulatory factors; 
the RISC assembly is a crucial point due to the presence of different Ago proteins 
and the miRNA seems to be more stable once assembled into the RISC complex. 
MicroRNAs are subject to turnover, not only at the mature level, but also at the 
precursor level, and are controlled by multiple levels of feedback loops (Kim et al., 
2009; Krol et al., 2010; Siomi and Siomi 2010; Ha and Kim, 2014).  
Once incorporated into the silencing RISC complex, a miRNA could pair to a mRNA, 
and represses it by inhibiting translation and/or inducing degradation of the target 
mRNA (Selbach et al., 2008). A single miRNA could regulate the expression of 
hundreds of genes because it binds 3’UTR of different mRNA targets with a perfect 
or an imperfect complementarity. 
 
 
2.9 myomiR and miR-1 
microRNAs are expressed in all tissues, and miRNA specifically expressed in muscle 
cells are known as myomiR. The myomiR family is composed of miR-1, miR-133a, 
miR-206, miR-208a, miR-208b, miR-499, and miR-486 (Fig. 15). They are expressed 
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both in heart and skeletal muscle, except miR-208a, which is cardiac specific 
(McCarthy, 2011).  
 
 
Fig. 15: myomiR: muscle-specific microRNA (McCarthy, 2011). 
 
Recent studies demonstrate that myomiR are involved in different aspects of muscle 
and heart function, in particular they are involved in myoblast proliferation, 
differentiation, and contractility and in different heart diseases like, cardiac 
hypertrophy, heart failure, and arrhythmias. For example, miR-133 seems to promote 
myoblast proliferation and it is linked to cardiac arrhythmias inhibiting the expression 
of HERG, the molecular component of the repolarizing current IKr; miR-208 is 
involved in a switch from α- to β-MHC, in cardiac hypertrophy and fibrosis.  (van Rooij 
et al., 2008).  
miR-1 is one of the main myomiR and the most abundant miRNA in human and 
mouse heart; miR-1 starts to be expressed in mouse heart at day 8.5 of development 
with a strong increase after birth (Lagos-Quintana et al., 2002).  
miR-1 is encoded by two genes (miR-1-1 and miR-1-2): miR-1-1 is located into the 
intron 2 of an uncharacterized gene on chromosome 20, while miR-1-2 is located into 
the intron 12 of the MIB1 gene on chromosome 18. Although separate genes encode 
miR-1-1 and miR-1-2, they are identical in sequences. Deletion of miR-1-1 or miR-1-2 
results in an analogue phenotype in mice: incompletely penetrant lethality, 
cardiomyocytes proliferative defects, and electrophysiological abnormalities; while 
the double knock-out is lethal before weaning. miR-1-null cardiomyocytes have 
abnormal sarcomere organization (Zhao et al., 2007; Heidersbach et al., 2013). 
Over-production of miR-1 during heart development in mouse results in defective 
ventricular myocytes proliferation (Callis and Wang, 2008).  
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Fig. 16: miRNA roles in heart development and function. miR-1 is involved in arrhythmias, defective 
ventricular septation, cardiac hypertrophy and myocytes hyperplasia (Callis and Wang, 2008). 
 
miR-1 was also shown to be involved in differentiation of mouse and human 
embryonic stem cells in embryoid bodies (EBs) which recapitulate embryonic 
development; in particular, miR-1, together with miR-133, promotes the mesoderm 
formation and they are potent repressor of non-muscle gene expression, suppressing 
the ectodermal and mesodermal differentiation. During the following stages of 
differentiation, miR-1 has opposite effects compared to miR-133, indeed miR-1 
promotes both cardiac and skeletal muscle differentiation, while miR-133 inhibits 
them (Ivey et al., 2008).  
 
 
Fig. 17: role of miR-1 and miR-133 during mESCs differentiation (Ivey et al., 2008). 
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It was demonstrated that different microRNAs could regulate cardiac excitability and 
arrhythmogenesis, in particular abnormal expression of miR-1 seems to be involved 
in cardiac arrhythmias and atrial fibrillation (AF), even though their role is still 
controversial: miR-1 is reduced in samples of AF patients, while results increased in 
samples from patients with coronary artery diseases. It was also demonstrated that 
reduction of miR-1 levels significantly reduces arrhythmias in rats infarcted 
myocardium, while injection of miR-1 promotes it. It is well known that AF is 
characterized by electrical remodeling due to ion channels alterations and structural 
remodeling, and it was demonstrated that miR-1 also regulates, directly or indirectly, 
the expression levels of some ion channels (HCN2, HCN4, KCNJ2, KCND2) and the 
level of connexin 43, reinforcing the idea that miR-1 could be involved in cardiac 
arrhythmogenesis (Girmatsion et al., 2009; Duan et al., 2014; Yang et al., 2007; 
Santulli et al., 2014).  
miR-1 is also involved in cardiac remodeling and in particular in cardiac hypertrophy, 
myocardial infarction and heart failure. The miR-1 levels are down-regulated in 
different kinds of cancer like rhabdomyosarcoma, lung, bladder and prostate cancer 
(Li et al., 2014).  
 
 
2.10 miR-423 
miR-423 is located in a region of chromosome 17q11.2. It was demonstrated that 
miR-423-5p is a suitable circulating biomarker for heart failure (HF), and its 
upregulation in blood of patients with HF is associated with an upregulation of miR-
423 in failing myocardium, suggesting that the increased circulating miR-423 is 
derived from the myocytes (Tijsen et al., 2010). Miyamoto and coworkers analyzed 
the levels of miR-423-5p in human serum and in pericardial fluid (PF) and they found 
that its level is significantly higher in PF than in serum. Furthermore, they found that 
the levels of miR-423 are elevated in serum of patients with unstable angina pectoris 
compared with those of patients with stable angina pectoris or patients with aortic 
valve replacement due to aortic stenosis (Miyamoto et al., 2015). Bauters and 
collaborators found that miR-423 is not a useful marker for myocardial infarction 
(Bauters et al., 2013). Li and coworkers demonstrated that miR-423-5p is 
dramatically increased in patients with dilated cardiomyopathy, and its introduction in 
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human cardiomyoblasts reduces the proliferation and induces apoptosis. They also 
found Grb-associated binders 1 (Gab 1) as potential target using a luciferase assay 
(Li et al., 2016).  
miR-423-5p was also found upregulated in colon cancer stem cells and a single 
nucleotide polymorphism (SNP) in pre-miR-423 was associated with breast cancer 
(Zhang et al., 2011; Wang et al., 2013; Zhao et al., 2015).  
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3. Aim 
 
Endurance athletes display structural and functional cardiac modifications with the 
most common being sinus bradycardia. D’Souza and coworkers demonstrated in 
trained animal models (mice and rats) that this sinus bradycardia is due to an intrinsic 
modification of the cellular pacemaking mechanism, rather than a modification of the 
vagal tone on the heart (D’Souza et al., 2014). In particular, they found that in SAN 
cells of trained mice there is a reduction of the funny current, the main contributor to 
the slow diastolic depolarization (DiFrancesco et al., 1986 b); they also demonstrated 
an upregulation of miR-1, one of the muscle-specific miRNA (myomiR) in the SAN of 
trained mice (D’Souza et al., 2014). Preliminary unpublished data from our 
collaborators in Manchester also indicated an up-regulation of miR-423 in SAN of 
trained mice. Both miR-1 and miR-423 directly bind the 3’UTR of HCN4 channels, the 
molecular constituent of the funny current. Starting from this evidence, the aim of our 
work is to evaluate the specific effects of miR-1 and miR-423 up-regulation in 
sinoatrial-like cells obtained from mESCs.  
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4. Methods 
 
4.1 Plasmids  
In order to obtain the mESC lines overexpressing the microRNAs of interest, we used 
three different constructs within the same plasmids (Fig. 18). The plasmid contained 
the miRNA of interest (or no miRNA as a control), the eGFP sequence under the 
same constitutive promoter (CMV), and the puromycin and ampicillin resistant 
cassette. 
All plasmids are a kind gift of the Professor Mark Boyett, from the University of 
Manchester, and derived from GeneCopeia.  
 
 
Fig. 18: general map of the plasmids, used for the overexpression of miR-1, miR-423 and the empty 
vector as control. 
 
 
4.2 Plasmidic DNA extraction  
Competent E. Coli cells were transformed with the three different plasmids. Bacteria 
were grown in culture LB (Luria Bertani) medium at 37°C with constant shaking over-
night. Ampicillin at the concentration of 50μg/mL was added to the LB medium.   
Plasmids were isolated using the commercial kit NucleoSpin® Plasmid Mini Prep 
Macherey-Nagel® as follows. 5mL of saturated E.Coli LB culture were centrifuged 
at 4’000xg for 15 minutes. Once discarded the supernatant, the pellet was 
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resuspended in 250μL of Buffer A1 and then 250μL of buffer A2 were added and 
mixed gently. At the end of 5 minutes of incubation at room temperature, 300μL of 
buffer A3 were added and mixed thoroughly; the solution was centrifuged for 5 
minutes at 11’000xg at room temperature. The supernatant was transferred into a 
NucleoSpin® Plasmid Column and subsequently centrifuged for 1 minute at 
11’000xg. The flow-through was thrown away, 600μL of buffer A4 were added to the 
column and centrifuged for 1 minute at 11’000xg and the flow-through discarded 
again. The column was centrifuged another time for 2 minutes at 11’000 x g and then 
the column was placed in a new collection tube and the DNA was eluted in 50μL of 
milliQ water centrifuging for 1 minute at 11’000xg.  
 
 
4.3 mESC culture  
Mouse embryonic stem cells (mESC; D3 line, ATCC) were cultured in feeder-free 
condition in culture medium contained KO-DMEM (Gibco), 15% Knock-Out Serum 
Replacement (Gibco), 0.1 mM Non Essential Amino Acids (Sigma-Aldrich), 0.1mM β-
mercaptoethanol (Sigma-Aldrich), 2mM L-glutamine (Sigma-Aldrich), 103U/ml 
Leukemia Inhibitory Factor (LIF, GeneSpin), 100U/ml Penicillin and 0.1mg/ml 
Streptomycin (Sigma-Aldrich). Cells were splitted two times in a week, using Tryple 
Express (Gibco) in order to avoid an excessive growth and uncontrolled 
differentiation. 
  
 
4.4 mESC electroporation 
Three batches of 2x106 mESC were electroporated with the proper plasmid: one 
containing the miR-1 sequences, one containing the miR-423 sequences, and the 
empty vector as control. The electroporation procedure was carried out using a 
commercial kit composed by 82μL of Nucleofector solution and 18 μL of Supplement 
(Lonza) to which we added 10μg of plasmid with a concentration between 1 and 5 
μg/μL. We used the electroporator Nucleofactor® II (Amaxa Byosystems) with the 
A24 program, specific for embryonic stem cells. Once electroporated, cells were kept 
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in stringent selection for 2 weeks with puromycin 1μg/mL. Non-electroporated cells 
were treated with the same concentration of puromycin as control.  
 
 
4.5 Selection of eGFP positive cells 
Colonies of mESCs were divided with Tryple Express, centrifuged, resuspended in 
culture medium, and filtered through a 70μm syringe filcons (BD Biosciences) , in 
order to obtain a homogeneous suspension of single cells. This procedure was 
repeated for each cell line. Cells obtained were analyzed using a cytometer (BD 
FACS Aria II), mESCs D3 were used to set the basal fluorescence, and the resulting 
eGFP positive cells were sorted to isolate only the cells where the plasmid was 
properly integrated.  
 
 
4.6 Differentiation of mESCs in cardiomyocytes  
ES cells were differentiated using the Hanging Drop technique, previously described 
by Maltsev (Maltsev et al., 1993). The hanging drops, containing ~500 cells in 20μL 
of differentiating medium (2.5x104 cellule/mL), were cultured for 2 days hanged in 
bacterial dishes up side down and then grown for further 5 days in the plate flooded 
with differentiating medium. 7 day-old Embryoid Bodies (EBs) were plated on tissue 
culture dishes coated with gelatin 0.1% (Type B, Sigma) in differentiating medium. 
The differentiating medium contains: DMEM (Gibco), 4mM L-glutamine (Gibco), 
0.1mM Non Essential Amino Acids (Sigma-Aldrich), 0.1mM β-mercaptoethanol 
(Sigma-Aldrich), 20% Fetal Bovine Serum (FBS) (Gibco), 1mM Sodium Pyruvate 
(Sigma-Aldrich), 100U/ml Penicillin, 0.1mg/ml Streptomycin. 
EBs usually displayed spontaneous beating activity at day 7 of differentiation, proving 
the proper differentiation and presence of cardiomyocytes. 
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Fig. 19: schematic representation of mESCs differentiation using the Hanging Drop technique. 
(Modified from Barbuti and Robinson, 2015) 
 
 
4.7 Selection of CD166+ cells using a cell sorter 
At day 8 of differentiation the EBs were detached from the plate and collected in a 
tube and allowed to sediment on the bottom by gravity. They were then washed two 
times with PBS (Phosphate Buffered Saline) and, after 10 minutes of incubation in 
presence of Tryple express at 37°C with constant shaking, they were mechanically 
dissociated to single cells. Cells were suspended in a solution of PBS with 1mM 
CaCl2, 10% FBS, and 5mM EDTA, and subsequently counted. 
Cells were incubated with the PE-conjugated rat anti-mouse CD166 antibody 
(eBioscience) for 30 minutes at 4°C under constant shaking, using 2.5μg of Ab for 
106 cells. 3x105 cells were incubated with the corresponding isotype (PE rat IgG). At 
the end of the incubation, cells were washed twice with the solution of PBS with 1 
mM CaCl2, 10% FBS, and 5mM EDTA, and then resuspended in the same solution. 
Finally, they were filtered with 70μm syringe filcons for the subsequent FACS 
analysis. Using the cell sorter CD166+ and CD166- cells were separated and used 
for the subsequent analysis. 
For the electrophysiological experiments, cells were put to re-aggregate for 24 hours 
in 1mL of differentiating medium in a low adhesion bacterial dishes, inclined at 45°, 
and then plated in a silicon support in a cell culture dish at the density  of 105 
cells/mm2 in 15μL of differentiating medium. Around the silicon support, we added 
1mL of differentiating medium to prevent the evaporation of the 15μL of medium. 
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After 4 hours the silicon support was removed, and the medium increased to 2mL. 
The medium was changed every 24/48 hours, until the electrophysiological analysis. 
To obtain single cells to perform voltage clamp experiments, we dissociated the 
aggregates of sinoatrial-like cells (CD166+) using 100μL of Trypsin-EDTA (Sigma-
Aldrich) diluted 1:2 with PBS. Dissociation was performed in subsequent steps, and 
the isolated cells obtained from each step were plated in a cell plate with a diameter 
of 35mm, previously filled with 2mL of differentiation medium with Ara-C. Medium 
was changed after 6 hours from dissociation.  
 
 
4.8 Isolation of sinoatrial node from mice 
Sinoatrial nodes (SAN) were isolated from 10 month-old female mice. 
The heart, quickly removed, was placed in cold Tyrode solution (mM: NaCl, 140; KCl, 
5.4; CaCl2, 1.8; MgCl2, 1; D-glucose, 5.5; Hepes-NaOH, 5; pH 7.4) containing 1000 
units of heparin to prevent blood clots formation, and the SAN tissue was dissected 
and conserved in liquid nitrogen until the RNA isolation. Animal protocols conformed 
to the guidelines of the care and use of laboratory animals established by Italian (DL. 
26/2014) and European (2010/63/UE) directives.  
 
 
4.9 RNA Extraction 
Tissues were resuspended in 1mL of TRIzol Reagent (Life technologies) and put into 
a potter to be mechanically homogenized and then further processed through the 
needle of an insulin syringe. After that, the protocol required the following steps: 
1. The tube was centrifuged for 10 minutes at 12’000xg at 4°C; 
2. The supernatant was moved into a new tube; 
3. 200μL of chloroform-isoamyl-alcohol (Sigma) were added; 
4. The tube was inverted 10 times and kept 4 minutes at room temperature (RT); 
5. The tube was centrifuged for 20 minutes at 12’000xg at 4°C, at the end of the 
centrifuge there was the formation of three phases: at the top a colorless 
aqueous phase with the RNA, in the middle an interphase with DNA, and at 
the bottom a red phase with proteins and lipids; 
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6. The aqueous phase was transferred in a new tube, where an equivalent 
volume (400-500μL) of isopropanol and 1μL of glycogen was added; 
7. The tube was inverted ten times and then the RNA was precipitated 10 
minutes at RT or overnight at -20°C; 
8. The tube was centrifuged for 20 minutes at 12’000xg at 4°C, and at the end of 
the centrifuge a RNA pellet formed at the bottom of the tube; 
9. The RNA pellet was washed with 1mL of ethanol at 75%; 
10. The tube was centrifuged for 10 minutes at 7’500xg at 4°C; 
11. The ethanol was removed and the tube allowed to dry; 
12. The RNA pellet was resuspended in milliQ water and quantified using a 
spectrophotometer.  
 
For RNA extraction cells were resuspended in 1mL of TRIzol Reagent and then 
mechanically homogenized through the needle of an insulin syringe. The protocol 
was continued from step 3 above. 
 
 
4.10 DNase treatment  
The RNA was treated with DNase I (Thermo Scientific) in order to remove any 
presence of genomic DNA. 1μg of RNA was treated with 1μL of DNase I (1U/μL), in a 
solution of MgCl2 in a final volume of 10μL of milliQ water. 
After 30 minutes at 37°C 1μL of EDTA 25mM (Thermo Scientific) was added and 
then put at 65°C for 10 minutes.  
The RNA was stored at -80°C. 
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4.11 Reverse transcription from RNA to cDNA for miRNAs 
A specific reverse transcription kit from Qiagen® was used to evaluate the 
microRNAs levels in the RNA samples. miRNA were prepared as described in the 
table 1 and treated for 60 minutes at 37°C and for 5 minutes at 95°C. 
 
 
 Quantity  
RNA 250ng 
miR-39 Solution Work (1.6x108 copies/μL) 2.20μL 
High Specific Buffer 5X 4μL 
miR Script Nucleics Mix 10X 2μL 
miR Script RT Mix 10X 2μL 
milliQ Water 
To the final volume 
of 20μL 
 
Tab. 1: mix for miRNA reverse transcription. 
 
 
In the mix the miR-39, an exogenous miRNA from C. elegans, was added to be used 
as normalizer during the subsequent real-time PCR.  
During the reverse transcription the “NO RNA” was prepared as the control of the 
reaction, replacing the RNA sample with milliQ water.  
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4.12 Reverse transcription from RNA to cDNA for mRNAs 
For the study of mRNA expression, the reverse transcription was carried out using a 
commercial kit (Thermo Scientific). Samples were prepared as described in the table 
2 and incubated for 10 minutes at 25°C, for 15 minutes at 50°C and for 5 minutes at 
85°C.  
 
 
 Quantity  
RNA 1μg 
Reaction Mix 5X 4μL 
Maxima Enzyme 10X 2μL 
milliQ Water 
To the final volume 
of 20μL 
 
Tab. 2: mix for mRNA reverse transcription. 
 
During the reverse transcription the “NO RNA” was prepared as control of the 
reaction, replacing the RNA sample with milliQ water.  
 
 
 
4.13 Real-Time qPCR 
The cDNAs obtained were analyzed using quantitative real-time PCR, (Line-
gene9600, Bioer). Each sample was analyzed in a technical triplicate and in each 
real-time the “NO RNA” and the “NO DNA” (a qPCR sample with milliQ water instead 
of cDNA) were analyzed as negative controls. All the data were expressed as  
2-ΔCtx100±SEM. 
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miRNA expression: 
The qPCR for micrRNA was performed using the mix indicated in table 3 for each 
sample. Expression of miR-1 and miR-423 were normalized on miR-39 expression. 
 
 Quantity  
cDNA 2.5ng 
Universal Primer 10X 2.5μL 
Primer miR 10μM 1.25μL 
QuantiTect SYBER Green PCR master Mix 2X 12.5μL 
milliQ Water 
To the final volume 
of 25μL 
 
Tab. 3: mix for real-time qPCR (miRNA). 
 
 
The forward primers were specific for each microRNAs analyzed (Tab. 4), while the 
reverse primer was the same and was the “Universal Primer” provided in the kit.  
 
miRNA FWD PRIMER 
mmu -miR-1a-1-3p TGGAATGTAAAGAAGTATGTAT 
mmu -miR-423-5p TGAGGGCAGAGAGCGAGACTTT 
miR-39 TCACCCGGGTGTAAATCAGCTTG 
 
Tab. 4: miRNA Primers (Sigma-Aldrich). 
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The PCR conditions were: 
 95°C for 15 minutes 
 94°C for 15 seconds 
 55°C for 30 seconds 
 70°C for 30 seconds 
 
 
The last three stages were repeated for 50 cycles, and the last one was the detection 
stage. 
 
 
mRNA expression: 
The qPCR for mRNA was performed using the mix indicated in table 5 for each 
sample. Expression of different genes were normalized on the expression of GAPDH 
(Glyceraldehyde 3-phosphate dehydrogenase).  
 
 
 Quantity  
cDNA 10ng 
Forward Primer 10X 1.25μL 
Revers Primer 10μM 1.25μL 
SYBER Green 2X 12.5μL 
milliQ Water 
To the final volume 
of 25μL 
 
Tab. 5: mix for real-time qPCR (mRNA). 
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The forward and the reverse primers are listed in the table 6. 
 
Gene FORWORD PRIMER FORWORD PRIMER 
HCN4 
GTCGGGTGTCAGGCGGGA  
 
GTGGGGGCCACCTGCTAT  
 
α-Act 
GCGGATATCGATGTCACAC  
 
AAACTGTGTTACGTCGCCC  
 
Tbx18 
TGATGGCCTCCAGAATGC  
 
CCGAGACTCTGGGAGGAAC  
 
Shox2 GAAAGGACAAGGGCGTCAC  
AACGTAGGTGCTTTAAGGATGC  
 
Oct4 
CTCCTTCTGCAGGGCTT  
 
GTTGGAGAAGGTGGAAAC  
 
Rex1 
GGGCACTGATCCGCAAAC  
 
CAGCAGCTCCTGCACACAGA  
 
GAPDH 
TGTAGACCATGTAGTTGAGGTCA  
 
AGGTCGGTGTGAACGGATTTG  
 
  
Tab. 6: primers (Sigma-Aldrich) used for real-time qPCR. 
 
  
The PCR conditions were: 
 95°C for 15 minutes 
 95°C for 15 seconds 
 60°C for 30 seconds 
 72°C for 30 seconds 
 
The last three stages were repeated for 45 cycles, and the last one was the detection 
stage. 
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4.14 Electrophysiological Analysis 
Our standard patch-clamp setup includes: 
- Inverted microscope (Axiovert S100) positioned on an anti-vibration table. 
- Patch-clamp amplifier (Axopatch 200B, Axon Instruments). 
- Digital interface (Digidata 1550B, Axon Instruments). 
- Micromanipulators. 
- Solution temperature control. 
- pClamp 10.6 software (Axon Instruments). 
All the electrical devices were positioned inside a Faraday’s cage, to shield from 
electrical noise. 
Electrophysiological experiments were performed using glass pipettes with a 
resistance of about 5-8mΩ when filled with a solution containing (): K-Aspartate, 130 
mmol/L; NaCl, 10 mmol/L; EGTA-KOH, 5 mmol/L; CaCl2, 2 mmol/L; MgCl2, 2 
mmol/L; ATP (Na-salt), 2 mmol/L; creatine phosphate, 5 mmol/L; GTP (Na-salt), 0.1 
mmol/L; pH 7.2.  
Electrophysiological protocols were designed with pClamp software. All data were 
acquired with pClamp software and an Axopatch 200B amplifier. To record the 
capacitive current, we used a protocol with a single hyperpolarizing step of 10 mV 
amplitude (from -35 to -45mV) for 30 ms of duration. 
Action potentials were recorded in current-clamp configuration during the perfusion of 
Tyrode solution. The extracellular solution used to record the If current was Tyrode 
with the addition of BaCl2 (1µM) and MnCl2 (2µM) to improve If dissection over other 
ionic components. 
The activation curve of If current was obtained by hyperpolarizing steps to the range -
35/-125mV, followed by a fully activating 1.5s step at -125mV, from a holding 
potential of -35mV. The duration of the first step was decreased as the activation of 
the current became progressively faster. Current amplitudes were normalized for the 
cell capacitance to obtained current densities (pA/pF). After normalization to 
maximum amplitude, tail currents measured at -125mV were fitted using Boltzmann 
equation:  
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- “V”: voltage. 
-  “y”: fractional activation. 
- “V1/2”: half activation voltage. 
- “s”: inverse-slope factor. 
 
 
 
4.15 Immunofluorescence Analysis  
The immunofluorescence protocol consisted in: 
 30 minutes of fixation with 4% paraformaldehyde (Sigma-Aldrich) at 4°C; 
 Two washes of 10 minutes with PBS supplemented with Glycine (0.1M); 
 30 minutes of permeabilization at RT, with PBS and 1.5% Triton (Sigma-
Aldrich); 
 One hour of block with PBS with 1% BSA (Sigma-Aldrich), 0.3% Triton, and 
10% serum; 
 Incubation over night with primary antibodies (Tab. 7), in a solution of PBS 
with 1% BSA, 2% serum, and 0.1% Triton, in a wet chamber; 
 Three washes of ten minutes each one with PBS; 
 One hour of incubation with the secondary antibodies (Tab. 8), in a solution of 
PBS with 1% BSA, 2% serum, and 0.1% Triton, in a wet chamber; 
 Three washes of ten minutes each one with PBS; 
 30 minutes of incubation with DAPI (4' 6-diamidino-2-phenylindole), at RT; 
 Two washes of three minutes each with PBS; 
 At the end the cover glass was assembled with the Fluorescent Mounting 
Medium (Dako) and fixed with clear nail polish.  
 
The fluorescence images were acquired using a Video Confocal microscope (ViCo, 
Nikon).  
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Primary antibody  Dilution 
Rabbit anti-HCN4 
(AlomooneLabs) 
1:100  
 
Mouse anti-α-Act 
(Sigma-Aldrich) 
1:1000 
 
 
Tab. 7: primary antibodies, and dilution used. 
 
 
 
Primary antibody  Dilution Fluorophore 
Donkey anti-mouse 
(Molecular Probes) 
1:500 
 
Alexafluor 488 
Donkey anti-rabbit 
(Molecular Probes) 
1:500 
 
Alexafluor 594 
 
Tab. 8: secondary antibodies, and dilution used.  
 
 
 
4.16 Isolation of Neonatal rat ventricular cardiomyocytes  
The ventricular myocytes were isolated from 3-day-old neonatal CD1 rats. 
Animals were sacrificed and the heart removed and kept in PBS at 4°C. Once 
removed the atria, ventricles were chopped in small pieces and put in an enzymatic 
solution; 300μL of solution were used for each heart (ADS 1X: NaCl 116.4mM; KCl 
5.4mM; NaH2PO4•H20 1mM; MgSO4•H20 0.8mM; HEPES 20mM; Glucose 5.5mM; 
Collagenase I 136U/mL; Pancreatin 0.4mg/mL; pH 7.4). 
After 20 minutes of digestion at 37°C under constant shaking, the solution containing 
the cells was removed, and diluted with 1mL of FBS for each heart and centrifuged at 
310xg for 5 minutes. Once discarded the supernatant, the pellet of cells was 
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resuspended in FBS and conserved in ice. The procedure was repeated at least 5-6 
time. At the end of all digestion cells were centrifuged again and resuspended in 
maintaining medium (M199; 10% Horse Serum; 5% FBS; 100U/mL Penicillin; 
0.10mg/mL Streptomycin; 2mM L-glutamine), and plated two times in a cell culture 
plate (diameter 100mm) for 40 minutes, to enrich the number of cardiomyocytes 
exploiting the capacity of fibroblasts to attach faster to the plate. After these two pre-
plating, the cells were counted and 800’000 cells were put in each plate of 35mm.  
To reduce fibroblasts proliferation 2.5μM arabinofuranosyl Cytidine (Ara-C, Sigma-
Aldrich) was added to the medium. The day after the isolation the percentage of 
Horse Serum was reduced from 10% to 5%.  
 
 
 
4.17 Transfection of neonatal rat ventricular 
cardiomyocytes 
The day after the isolation, cardiomyocytes were transfected with the plasmid 
containing the miR-423 sequence and, in parallel, with the empty plasmid using 
Lipofectamine® 2000 (Life Technologies) using the following protocol: the mix A 
(242.5μL of Opti-MEM and 7.5μL of Lipofectamine) was prepared in a low adhesion 
tube and, after 5 minutes, the mix B (1.5μg of plasmid in a final volume of Opti-MEM 
of 250μL) was added. After 20 minutes, 500μL of the final mix and 1.5mL of medium 
were added to the plates containing the cells.  
36 hours after the transfection, to obtain small aggregates of cells, cardiomyocytes 
were enzymatically digested with Trypsin for 2-3 minutes at 37°C and then 
mechanically dissociated; after 5 minutes of centrifuge at 310xg cells were 
resuspended in the maintaining medium and plated at the right density. Since the 
plasmid presents both the eGFP and the miRNA sequences under the control of the 
same promoter, cells expressing the green fluorescent protein were used for the 
electrophysiological experiments. 
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5. Results 
 
5.1 miR-1 and miR-423 directly binds the 3’UTR of HCN4 
mRNA 
Our collaborators in Manchester demonstrated that miR-1 and miR-423 are both up-
regulated in the SAN of trained mice, and that the heart of trained mice display 
intrinsic bradycardia. Mice were trained for 4 weeks by a swimming protocol of  60 
minutes twice in a day. Knowing that the If current is mediated by the HCN4 channels 
in SAN cells, and that it is fundamental for the setting of the heart rhythm, they  
investigated if these two microRNAs could regulate HCN4 expression. To do this, 
they performed a luciferase reporter assay: the HCN4 3’UTR region was cloned in a 
plasmid in frame with the luciferase sequence. In case of binding of the miRNA to the 
3’UTR, we expect a reduction of the luciferase transcription and thus of its activity. As 
shown in figure 20, our collaborators demonstrated that both miR-1 and miR-423 
directly bind to the 3’UTR of HCN4 channels.   
 
 
 
 
Fig 20:  bar graph of luciferase report assay: miR-1 and miR-423 lead to a reduction of the luciferase 
activity and so it is possible to conclude that they directly bind the 3’UTR of HCN4 channels. 
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5.2 Generation of mESC lines stably overexpressing miR-1 
and miR-423  
In order to study the effects of miR-1 and miR-423 overexpression on the 
electrophysiological properties of pacemaker cells, we need to transfect cells with 
plasmids containing the miRNA of interest under the control of a strong promoter. 
Only the last year, it was demonstrated that it is possible to keep in culture sinoatrial 
cells isolated from adult mice, and that it is possible to infect, but not transiently 
transfect them. Moreover, in this way, it is possible to obtain and analyze just a little 
number of cells (St. Clair et al., 2015). Consequently, we decided to study the role of 
these two microRNAs in sinoatrial-like cells isolated from 8 day-old Embryoid Bodies 
(EBs) obtained from engineered mESCs, following a specific protocol developed in 
our laboratory (Scavone et al., 2013). 
To obtain sinoatrial-like cardiomyocytes overexpressing miR-1 and miR-423, three 
batches of mESCs were electroporated with three different plasmids: one containing 
the miR-1 sequence, one containing the miR-423 sequence under the control of a 
strong constitutive promoter (CMV) and the corresponding empty plasmid. Thanks to 
the presence of the puromycin resistance cassette, cells were kept under stringent 
antibiotic selection (1μg/mL) for at least two weeks in order to induce integration of 
the plasmid into the genome. After this stringent selection, the antibiotic 
concentration was lowered to 0.5μg/mL for maintenance. The effect of puromycin 
selection was checked on non-electroporated mESCs (mESC-D3), which all died 
after 24-48 hours of selection.  
Since the miRNA-containing plasmids have also the eGFP under the same promoter, 
two weeks after the puromycin selection, we isolated only eGFP-positive cells, using 
a cells sorter, in order to obtain only a population of cells in which the plasmid is 
properly integrated. 
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Fig 21:  representative flow cytometer analysis (dot plots) of eGFP positive cells derived from non-
electroporated mouse embryonic stem cells (mESC-D3), mouse embryonic stem cells electroporated 
with the miR-1 plasmid (mESC-miR-1), mouse embryonic stem cells electroporated with the miR-423 
plasmid (mESC-miR-423), and mouse embryonic stem cells electroporated with the empty plasmid 
(mESC-empty). 
 
 
At the end of this procedure, we evaluated the effective overexpression of miRNAs 
using real-time quantitative PCR: as evident from the bar graph of Fig. 22 miR-1 is 
more than 2x104 times up-regulated in ES cells electroporated with the miR-1 
plasmid compared to those electroporated with the empty vector (mESC-miR-1 
35.12±5.64 vs mESC-empty 2.2*10-4±6.5x10-4; n≥6), while miR-423 results   3 times 
up-regulated in ES cells electroporated with the miR-423 plasmid compared to those 
electroporated with the empty vector (mESC-miR-423 5.17±0.40 vs mESC-empty 
1.91±0.59; n=4). 
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Fig 22: (A) mean expression of miR-1 in mESC-empty (grey, n=6) and in mESC-miR-1 (green, n=7). 
(B) Mean expression of miR-423 in mESC-empty (grey, n=4) and in mESC-miR-423 (purple, n=4). 
Note the difference in the y scale.  * p<0,05 (t-test).   
 
 
This protocol allows to obtain for each transfection, one stable cell line: the first one 
overexpressing miR-1 (mESC-miR-1), the second overexpressing miR-423 (mESC-
miR-423), and the last one containing the empty vector that will be used as a control 
(mESC-empty) during subsequent analysis. 
Afterwards, we evaluated the expression levels of two genes of pluripotency (Oct4 
and Rex1) in order to evaluate if the overexpression of each microRNAs by itself 
could alter the pluripotency of mESCs. In figure 23, mean expression data are 
presented showing no statistical differences between the four cell lines (mESC-D3, 
mESC-empty, mESC-miR-1, and mESC-miR-423) for Oct4, while we found a slight 
but significant up-regulation of Rex1 in the three engineered cell lines compared to 
the control line. 
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Fig 23:  mean expression of Oct4 mRNA (A)  and Rex1 mRNA (B) in mESC-D3 (blue, n=3), in mESC-
empty (grey, n=3), in mESC-miR-1 (green, n=4), and in mESC-miR-423 (purple, n=4) * p<0,05 
(ANOVA, Fisher test).   
 
 
5.3 Differentiation of mESC into sinoatrial-like 
cardiomyocytes with pacemaker phenotype  
We evaluated the ability of these cells to correctly differentiate into cardiomyocytes 
using the Hanging Drops technique, a well-established protocol that allows the 
formation of Embryoid Bodies (EBs), small compact cell aggregates that resemble  
early stages of the embryo development (Maltsev et al., 1994). After at least 7 days 
of differentiation, little regions of EBs start to beat spontaneously and the beating 
activity was monitored for the next 7 days; in the table 9 the percentage of beating 
EBs of the three mESCs lines is shown. These results suggest the effective 
differentiation of cells into cardiomyocytes and that the overexpression of miR-1 and 
miR423 did not alter the capacity of mESCs to properly differentiate into beating 
cardiomyocytes.  These results are in accordance with previously published data 
(Barbuti et al., 2009). 
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 mESC empty mESC-miR-1 mESC-miR-423 
7+1 85.2±5.4% (n=8) 87.6±3.2% (n=8) 92.0±5.1% (n=6) 
7+2 85.5±5.2% (n=8) 93.4±1.7% (n=8) 96.2±3.3% (n=6) 
7+3 78.6±7.0%  (n=5) 77.6±17.3% (n=5) 93.7±5.4% (n=3) 
7+4 78.8±6.3% (n=5) 96.6±2.2% (n=5) 98.7±0.7% (n=3) 
7+5 98.0±2.0% (n=3) 97.3±0.7% (n=3) 98.7±0.7% (n=3) 
7+6 98.0±2.0% (n=3) 91.7±9.3% (n=3) 94.0±2.1% (n=3) 
7+7 87.7±5.9% (n=8) 94.8±2.0% (n=8) 93.7±3.4% (n=6) 
 
Tab. 9:  mean percentage of beating EBs at different days of differentiation (from 8 to 14), obtained 
from mESC-empty, mESC-miR-1, and mESC-miR-423. 
 
 
In order to specifically isolate sinoatrial-like cells from EBs at day 8 of differentiation, 
we selected cells positive for the CD166 marker, since this protein is known to 
identify SAN progenitors from differentiating mESCs (Scavone et al., 2013).  
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Fig 24:  representative dot plot of CD166+ cells analysis at day 8 of differentiation from EBs obtained 
from mESC-empty, mESC-miR-1, and mESC-miR-423, the negative population is set for each line 
labeling cells with the proper isotype.    
 
CD166+ cells have been sorted and re-aggregated by gravity for 24h in low-adhesion 
culture dishes in differentiating medium, and subsequently plated at high density (105 
cells/mm2) in silicon inserts to allow the formation of a compact beating layer. Once 
plated, CD166+ cells formed, as expected, a compact aggregate of spontaneously 
beating sinoatrial-like cells. The bar graph of fig. 25, shows that the percentage of 
CD166 positive cells is statistically higher in mESC-miR-1 and mESC-miR-423, than 
in the control cell line (25.20±2.32 in CD166+-miR-1 vs 11.09±1.09 in CD166+-empty 
vs 18.56±1.36 CD166+-miR-423). 
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Fig 25:  mean percentage of CD166+ cells in EBs obtained from the differentiation of mESC-empty 
(grey, n=30), mESC-miR-1 (green, n=26), and mESC-miR-423 (purple, n=9) at day 8 of differentiation. 
* p<0,05 (ANOVA, Fisher test). 
 
After the sorting selection, we compared the α-Actinin expression in CD166+ and in 
CD166- cells, using quantitative real-time PCR: as expected, the CD166+ cells 
express α-Actinin at higher levels than CD166- cells (Fig. 26 and Tab. 10). 
 
 
Fig 26:  mean expression of α-Actinin mRNA in Empty-CD166- (dashed grey, n=10), Empty-CD166+ 
(grey, n=10), miR1-CD166- (dashed green, n=9), miR1-CD166+ (green, n=9), miR423-CD166- 
(dashed purple, n=7), and miR423-CD166+ (purple, n=7). No differences between all CD166- cell 
lines and no differences between all CD166+ cell lines (ANOVA, Fisher test). * p<0,05 (t-test between 
CD166+ and CD166- of all cell lines). 
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 CD166- CD166+ 
Empty 13.10±9.02 (n=10) 59.41±14.42 (n=10) 
miR-1 7.35±1.84 (n=9) 50.76±12.46 (n=9) 
miR-423 13.01±3.11  (n=7) 82.42±17.06 (n=7) 
 
Tab. 10:  mean expression of α-Actinin mRNA in CD166+ and CD166- cells of all three cell lines. Data 
are expressed as mean±SEM.  
 
We further evaluated the expression levels of some genes expressed and involved in 
the earliest stages of SAN differentiation (Shox2 and Tbx18), finding no differences in 
miR-1-CD166+, miR-423-CD166+, empty-CD166+, and SAN except for the Tbx18 
level in CD166+-miR-1, that was statistically higher than in the other samples (Fig. 
27; Tab. 11). These results support not only the idea that miR-1 is involved in the 
mesoderm and muscle-line differentiation, but also that the overexpression of the 
different plasmids does not affect the capacity of mESC to properly differentiate in 
sinoatrial-like cells. 
 
 
Fig 27: (A) mean expression level of Shox2 mRNA in mouse SAN (blue, n=5) and in CD166+ of empty 
line (grey, n=9), of miR-1 line (green, n=15), and of miR-423 (purple, n=6). (B) Mean expression level 
of Tbx18 mRNA in mouse SAN (blue, n=5) and in CD166+ of empty line (grey, n=10), of miR-1 line 
(green, n=14), and of miR-423 (purple, n=7).* p<0,05 (ANOVA, Fisher test).   
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 Shox2 Tbx18 
SAN 0.15±0.07 (n=5) 0.21±0.05 (n=5) 
Empty CD166+ 0.33±0.17 (n=9) 0.36±0.11 (n=10) 
miR-1 CD166+ 0.41±0.20 (n=15) 0.98±0.15 (n=14) 
miR-423 CD166+ 0.49±0.26  (n=6) 0.53±0.18 (n=7) 
Tab. 11:  mean expression of Shox2 and Tbx18 mRNAs in mouse SAN and CD166+ of empty, miR-1 
and miR-423 cell lines. Data are expressed as mean±SEM.  
 
 
Knowing that the expression of the If current, and in particular of the HCN4 isoform, is 
a necessary condition to properly identify SAN cells, and since miR-1 and miR-423 
bind to HCN4 3’UTR, we also evaluated the expression levels of HCN4 in the 
sinoatrial-like cells (CD166+ cells) obtained from the various lines (mESC-empty, 
mESC-miR-1, and mESC-miR-423), using quantitative real-time PCR. The bar graph 
(Fig. 28) shows no statistical differences between HCN4 levels in empty-CD166+, 
miR-1-CD166+, and miR-423-CD166+ (empty-CD166+ 3.00±0.41 n=15; miR-1-
CD166+ 3.08±0.40 n=14; miR-423-CD166+ 3.91±0.98 n=7). 
 
 
 
Fig 28:  mean expression of HCN4 mRNA in empty-CD166+ (grey, n=15), miR-1-CD166+ (green, 
n=14), and miR-423 (purple, n=7) * p<0,05 (ANOVA, Fisher test).   
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Furthermore, we analyzed the expression of HCN4 and α-actinin at the protein level 
in CD166+ cells of all three cell lines. Representative immunofluorescence images 
are shown in Figure 29. We did not observe any strong difference in the expression 
pattern. These results further confirm that the CD166+ cells isolated from EBs at day 
8 of differentiation from mESC-empty, mESC-miR-1, and mESC-miR423 are 
cardiomyocytes with sinoatrial properties.  
 
 
 
 
Fig 29:  confocal images of CD166-selected cells for empty, miR-1, and miR-423 lines: cells were 
stained with either the cardiac proteins α-Actinin (green) and HCN4 (red). Nuclei were stained with 
4',6-diamidino-2-phenylindole (DAPI). Calibration Bar 35μm. 
 
 
5.4 Electrophysiological analysis on sinoatrial-like cells 
We have then investigated the functional properties of sinoatrial-like cells by patch-
clamp analysis, in the whole-cell configuration. First, we performed current-clamp 
experiments in order to evaluate the spontaneous beating rate of the CD166+ layer. 
On average, miR-1-CD166+ cells showed a 38% reduction of the rate compared to 
the empty-CD166+ cells. No differences were instead found between miR-423-
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CD166+ and empty-CD166+ cells (miR-1-CD166+ 1.37±0.08 Hz n=10; miR-423-
CD166+ 2.36±0.30 Hz n=7; empty-CD166+ 2.22±0.22 Hz n=7) (Fig. 30). 
 
 
 
Fig. 30:  (A) representative traces of action potentials recorded from CD166+ cells of empty line 
(grey), of miR-1 line (green), and of miR-423 line (purple). (B) Mean action potential rate of CD166+ 
cells of empty line (grey), of miR-1 line (green), and of miR-423 line (purple). * p<0,05 (ANOVA, Fisher 
test).   
 
 
These data suggest that the miR-1 overexpression leads to a reduction of beating 
rate in sinoatrial-like cells, and we can assume that this slowdown of the rhythm is 
due to a reduction of If current. In order to verify this hypothesis, we carried out 
electrophysiological recording in voltage-clamp configuration on single cells 
dissociated from the compact beating layer of miR-1-CD166+ and empty-CD166+. 
The steady state current amplitude was measured in the range of potentials from -
35mV to -125mV with steps of 10mV, and these values were normalized to cell 
capacitance to obtain current densities. As evident from the representative traces of If 
current and from the mean current density plot, the funny current results statistically 
reduced in CD166+ overexpressing miR-1, whit a reduction of 50%. While there are 
no differences in the voltage dependence of the channels as evident from the 
activation curve (Fig. 31). 
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Fig. 31:  (A) representative traces of If current recorded from CD166+ cells of empty line (grey) and 
miR-1 line (green). (B) Plot of current density of CD166+ cells of empty line (grey) and miR-1 line 
(green). (C) Activation curve of funny current of CD166+ cells of empty line (grey) and miR-1 line 
(green).  * p<0,05 (t-test). 
 
 
 
 V1/2 Slope 
Empty 
CD166+ 
-72.69±1.55 (n=19) 6.77±0.53 (n=19) 
miR-1 
CD166+ 
-73.13±1.32 (n=30) 8.03±0.38 (n=30) 
 
Tab. 12:  mean V1/2 and slope of empty-CD166+ and miR-1-CD166+. Data are expressed as 
mean±SEM.  
 
 
56 
 
5.5 Expression of miR-1 and miR-423 in CD166+ cells 
We also decided to evaluate the expression levels of miR-1 and miR-423 in CD166+ 
cells, and as visible in the bar graph in figure 32, miR-1 results up-regulated in 
CD166+ cells, isolated from EBs differentiated from mESC-miR-1 compared to 
CD166+ cells isolated from the EBs obtained from the control line (mESC-empty) 
(mESC-miR-1 46.86±17.58, n=12; mESC-empty 3.01±1.72, n=10). While, 
surprisingly, we did not find any difference in the expression level of miR-423 in 
CD166+ positive cells isolated from EBs differentiated from mESC overexpressing 
miR-423 and the control (mESC-miR-423 1.24±0.85, n=7; mESC-empty 0.92±0.40, 
n=9) (Fig. 32).  
 
 
 
Fig. 32: (A) mean expression of miR-1 empty-CD166+ cells (grey, n=10) and miR-1-CD166+ (green, 
n=12). (B) Mean expression of miR-423 empty-CD166+ cells (grey, n=9) and miR-423-CD166+ 
(purple, n=7). Note the difference in the y scale. * p<0,05 (t-test).   
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5.6 Electrophysiological analysis of rat ventricular 
cardiomyocytes overexpressing miR423 
Since we found no differences in the expression levels of miR-423 between miR-423-
CD166+ and empty-CD166+, we decided to evaluate if the similar beating rate of 
these cells is due the insufficiently high expression of miR-423 or because miR-423 
does not affect the electrical properties of sinoatrial-like cells. To do this, we 
transiently transfect neonatal rat ventricular cardiomyocytes (NRVCs), that display 
spontaneous activity, with the miR-423 plasmid and with the control empty plasmid. 
After 48 hours of transfection, we recorded spontaneous action potentials (APs) from 
little aggregates of NRVCs, displaying green fluorescence. We did not  find 
differences in the mean beating rate of NRVC-empty (1.37±0.51Hz, n=3) and NRV-
miR-423 (1.57±0.30Hz, n=10) (Fig. 33). 
 
 
 
Fig. 33: representative traces (A)  and mean (B) of action potentials recorded from NRVC transfected 
with the empty plasmid (grey) or overexpressing miR-423 (purple).  
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6. Discussion 
 
It is well known that regular physical activity confers a plethora of health benefits. 
Endurance training requires electrical, structural, and functional adaptation of the 
heart in order to sustain the increased metabolic need and thus the cardiac output. 
This remodeling is referred as “Athletes Heart”. One of the most common adaptation 
in endurance athletes is deep bradycardia, a heart rhythm lower than 60 beats/min, 
with episodes of 30 beats/min. Endurance training bradycardia is commonly 
associated with an increased vagal tone, but recently it was demonstrated that in 
trained animals (rats and mice) it is due to an intrinsic modification of the pacemaker 
property of the heart, and in particular to a reduction of the funny current. This current 
is fundamental in the early diastolic depolarization phase of the action potential, and 
so for the setting of the heart rhythm (D’Souza et al., 2014). Recently, microRNAs 
(miRNAs) were discovered as novel modulators of pathologic and physiologic 
remodeling of the heart. D’Souza and co-workers demonstrated an up-regulation of 
miR-1, one of the main muscle-specific microRNAs, in the SAN of trained mice, and 
moreover they recently demonstrated that miR-423 is also up-regulated in SAN of 
trained mice and that both miRNAs directly binds the 3’UTR of the HCN4 channels, 
the main molecular component of the If current in SAN cells (D’Souza et al., 2014).  
We thus decided to study the role of these microRNAs on SAN function. SAN 
myocytes are difficult to isolate, the yield of cells is usually poor and they cannot be 
kept in culture for more than a couple of days. Only recently it was demonstrated, by 
St. Clair and collaborators, that sinoatrial myocytes from adult mice can be kept in 
culture for up to one week, that it is possible to infect them using adenovirus, but it is 
not possible to transiently transfect them, making very challenging working with them. 
Moreover, a huge problem is the small size of mice SAN and consequently the very 
small number of cells that it is possible to isolate that rapidly decreases in culture. St. 
Clair and colleagues also underlined the necessity to keep the BDM (2,3-
butanedione monoxime), a reversible contraction inhibitor, in the culture medium, a 
procedure that caused different side effects, such as the inhibition of different cardiac 
transcription factors and some ion currents (sodium and calcium) (St. Clair et al., 
2015). To overcame these limitations, we decided to study the role of these two 
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microRNAs in sinoatrial-like cells obtained from mESCs (Scavone et al., 2013) 
overexpressing miR-1 and miR-423. 
Since during cell electroporation the plasmid could be integrated casually into the 
genome, it is possible that the insertion in an important region could alter the 
fundamental properties of cells. For this reason, we decided to evaluate if the 
pluripotency of mESC is conserved in the various clones. Besides maintaining an 
elevated proliferative potential and a correct morphology (data not shown), analyzing 
the expression levels of Oct4 and Rex1, we demonstrated that all the three cell lines 
obtained maintain high expression levels of these two markers indicating that they 
have their pluripotency characteristics unaltered. In the same way it is possible that 
either the random integration of the plasmid or the overexpression or the miR by itself 
can interfere with the normal differentiation pathways. Thus, we also evaluated the 
capacity of our cell lines to properly differentiate into cardiomyocytes and we found 
that, using the Hanging Drop technique, they are able to form EBs that display 
spontaneous beating activity at day 7 of differentiation, according to what previously 
demonstrated in our laboratory using various mESC lines (Barbuti et al., 2009; 
Scavone et al., 2013). Knowing that microRNAs have diverse effects in different cells 
and conditions, in this way we also demonstrated that the miR-1 and miR-423 
overexpression do not affect the pluripotency of mESCs and neither their capacity of 
properly differentiate into cardiomyocytes, as previously showed by Ivey and 
collaborators for miR-1 (Ivey et al., 2008).  
The CD166+ cells obtained from all the three cell lines show comparable 
characteristics from those obtained by Scavone and coworkers, indeed CD166+ cells 
show higher level of α-Actinin than CD166- and they expressed α-Actinin and HCN4 
at protein level with an expression pattern comparable with of those of control cells 
(Fig. 34) (Scavone et al., 2013).  
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Fig. 34: confocal images of CD166+ cells labelled with α-Actinin (α-act, green) and HCN4 (red); nuclei 
were stained with DAPI. Calibration bars, 50 µm (modified from Scavone et al., 2013). 
 
 
In order to further confirm the proper differentiation of mESCs into cardiomyocytes 
with a sinoatrial-like phenotype we evaluated the expression level of Shox2 and 
Tbx18, two genes involved in the earliest stage of SAN development (Barbuti and 
Robinson, 2015). We found that CD166+ cells of all three cell lines express Shox2 
and Tbx18, at comparable levels with SAN of adult mice and in accordance with what 
previously found (Scavone et al., 2013). It is possible to observe only an up-
regulation of Tbx18 in miR-1-CD166+ in comparison to the control line. This result 
could be due to the fact that miR-1 is known to be involved in mesodermal and 
cardiac differentiation (Ivey et al., 2008). 
The percentage of CD166 positive cells, the sinoatrial-like cells, at day 8 of 
differentiation in EBs differentiated from mESC-miR-1 is statistically higher than those 
in EBs obtained from the control cell line, and this is in agreement with literature data, 
indeed it was demonstrated that miR-1 has a double function: first, it induces the 
mesodermal lineages, and then supports the muscle-line differentiation (Ivey et al., 
2008). From our results we can say that mESC-derived sinoatrial-like cells can be 
generated from mESC lines overexpressing the miR of interest and can thus be used 
as a cellular model to study the effects of miRNAs on pacemaking mechanisms. 
D’Souza and coworkers demonstrated that trained bradycardia is due to an intrinsic 
reduction of the beating rate of SAN cells, and to a reduction of the funny current, 
rather than a reduction of the vagal tone on the heart, but the molecular mechanism 
at the bases of this process is not completely understood. They also demonstrated 
that miR-1 is up-regulated in SAN of trained mice and hypothesized that these 
microRNAs could be involved in the mechanism at the basis of beating rate reduction 
of SAN of trained mice. Here we found that the miR-1-CD166+ cells display a 
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reduction of the beating rate and of the funny current, and so we can conclude that 
the overexpression of miR-1 is involved in the setting of the heart rhythm and in 
particular its overexpression induces a reduction of the action potential firing rate, 
modulating the If current of sinoatrial-like cells. These data are in accordance with the 
reduction of heart rate of trained mice and with the reduction of the beating rate and 
of the funny current of SAN cells isolated from trained mice founded by D’Souza and 
coworkers (D’Souza et al., 2014). So it is possible to speculate that the trained 
induced bradycardia may be due to a reduction of beating rate of SAN cells due to a 
reduction of the funny current mediated by an increase of miR-1 expression.  
We find no differences on the HCN4 mRNA levels in miR-1-CD166+ and in empty-
CD166+ cells, suggesting that the binding between miR-1 and HCN4 mRNA lead to a 
translational repression, rather than a mRNA degradation. This result is in contrast 
with the reduction of the HCN4 mRNA found by D’Souza and collaborators in SAN 
cells of trained mice and rats. This discrepancy could be explained by the different 
models used, indeed we studied only the overexpression of miR-1 in sinoatrial-like 
cells, while D’Souza studied a more complex model of trained mice, where the 
reduction of the HCN4 transcript could be due to other mechanisms like, for example, 
the modulation by other miRNAs. 
The activation curves of the If current obtained during the patch-clamp experiments, 
and recorded from the miR-1-CD166+ and empty-CD166+ are similar and, 
suggesting that the reduction of the funny current is due to a direct action of miR-1 on 
HCN4 mRNA in accordance with the results of our collaborators of Manchester that 
found a direct bind between miR-1 and the 3’UTR of HCN4 mRNA.  
Regarding miR-423, little it is known in the literature. At present, it is known that miR-
423 is associated with heart failure, unstable angina pectoris, and dilated 
cardiomyopathy; but it is not associated with myocardial infarction (Tijsen et al., 
2010; Bauters et al., 2013; Miyamoto et al., 2015). These data suggest that miR-423 
is altered in different cardiac pathology, but actually is not associated with rhythm 
disturbances. Our collaborators found an up-regulation of miR-423 in SAN of trained 
mice and, using the luciferase report assay, they demonstrated that it directly binds 
the 3’UTR of HCN4 mRNA. We thus studied the overexpression of miR-423 in 
sinoatrial-like cells, finding no differences in the AP firing rate compared with the 
control. 
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When we analyzed the expression levels of miR-423 in miR-423-CD166+ and in 
control cells, we found no differences, while this overexpression, although limited, 
was present in mESC-miR-423 cells. We currently don’t know why the miR-1 
overexpression persists after the differentiation of mESC, while the same result is not 
true for miR-423, but we supposed that this could be due to its limited overexpression 
(~3 times) respect the higher overexpression of miR-1 (~2x104) in mESCs after 
electroporation. Consequently, these results lead us to suppose that the 
electrophysiological data could be vitiated by the lack of miR-423 overexpression in 
sinoatrial-like cells. For this reason, we decided to study the effects of miR-423 
overexpression in another well-established excitable model, already used in our 
laboratory to study the functional role of some microRNAs in a cardiac context. 
Indeed, we transiently transfected neonatal rat ventricular cardiomyocytes with the 
miR-423 and control plasmids, and again we found no differences in the AP firing 
rate. These data suggest that, despite miR-423 is altered in SAN of trained mice and 
it directly binds the 3’UTR of HCN4 mRNA in the luciferase assay, it is not probably 
involved in the regulation of beating rate of trained mice. The discrepancies in the 
results are explainable by the fact that it is known from the literature that the same 
miRNA could have different effects in different cellular contexts, and it is increasingly 
clear that the results in vitro with the luciferase assay are not completely truthful and 
they must be confirmed with other experiments. However, it would be desirable to 
evaluate the expression level of miR-423 in rat ventricular cardiomyocytes 
transfected with the two plasmid before ruling out the role of miR-423; indeed it would 
be better to check that the lack of effect is not duo to a possible low expression of the 
plasmid also in this cellular model.     
All these data together lead us to conclude that miR-1 and miR-423 are up-regulated 
in SAN cells of trained mice, and they directly bind the 3’UTR of HCN4 channels. So 
it is possible to speculate that miR-1 is one of the microRNAs involved in the trained-
induced bradycardia in mice. These results provide us another important conclusion: 
in particular we demonstrated that this cellular model is exploitable to study the role 
of different microRNAs in a sinoatrial context. Knowing that microRNAs could have 
different effects in different cellular contexts, it is important to study the role of a 
microRNAs in the right and specific cellular model (Bartel, 2009). Since SAN cells are 
limited in number and not accessible, in particular in humans, for biological studies, it 
is important to find other ways to obtain this kind of cells to study the role of miRNAs. 
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Very recently, Protze and coworkers demonstrated that it is possible to isolate human 
sinoatrial-like cells from human pluripotent stem cells, and consequently it is possible 
to speculate that the combination of our technique and the differentiation and 
isolation protocol of Protze would make possible to study the role of microRNAs in 
human sinoatrial-like cells to better understand the mechanism at the basis of human 
heart rhythm (Protze et al., 2016).  
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